Is Anebulo Pharmaceuticals Inc (ANEB) overvalued? · $15.3M cap
Anebulo Pharmaceuticals Inc (ANEB) is a biotechnology company listed on US.
This page asks whether Anebulo Pharmaceuticals Inc (ANEB) looks expensive on cached numbers — not a short thesis.
No cached income statement for ANEB, so there is no earnings base to call rich or cheap.
ANEB currently screens at market cap $15.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ANEB 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ANEB stock page for the full model, not this heading.
Not investment advice.